Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

153
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
153
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.2K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.2K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

131
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
131
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

131
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
131
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

234
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
234

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimization Approach for Hydrogen Infrastructure Planning Under Uncertainty.

Industrial & engineering chemistry research·2025
Same author

Interpretable optimisation-based approach for hyper-box classification.

Machine learning·2025
Same author

Accelerating pharmaceutical tablet development by transfer of powder compaction equipment across types and scales.

International journal of pharmaceutics·2024
Same author

Empirical Model Variability: Developing a new global optimisation approach to populate compression and compaction mixture rules.

International journal of pharmaceutics·2024
Same author

Predicting drug solubility in organic solvents mixtures: A machine-learning approach supported by high-throughput experimentation.

International journal of pharmaceutics·2024
Same author

Optimisation-based modelling for explainable lead discovery in malaria.

Artificial intelligence in medicine·2024
Same journal

Approaches for enhancing bioavailability of macromolecular drugs.

International journal of pharmaceutics·2026
Same journal

Characteristics of asymmetric microcrystalline solidification pellets and a better prediction for bioequiavailability based on solubility-permeability theory.

International journal of pharmaceutics·2026
Same journal

A CFPD-FSI analysis of the impact of nasal hairs on airflow patterns, nasal resistance, and particle filtration in a realistic human nasal airway.

International journal of pharmaceutics·2026
Same journal

Transient hydrate formation during disintegration of film-coated pharmaceutical tablets.

International journal of pharmaceutics·2026
Same journal

Erratum to "In vitro - In vivo correlation modeling of an oxcarbezapine extended-release formulation using numerical deconvolution" [Int. J. Pharm. 699 (2026) 126952].

International journal of pharmaceutics·2026
Same journal

Use of a hydrophilic excipient to modulate the release of dapivirine, copper ions and zinc ions from a matrix-type vaginal ring.

International journal of pharmaceutics·2026
See all related articles

Related Experiment Video

Updated: Sep 17, 2025

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
09:28

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation

Published on: May 18, 2020

8.6K

A novel surrogate-based optimisation framework for pharmaceutical process systems.

Artemis Tsochatzidi1, Francesca Cenci2, Magdalini Aroniada2

  • 1The Sargent Centre for Process Systems Engineering, Department of Chemical Engineering, UCL (University College London), Torrington Place, London WC1E 7JE, UK.

International Journal of Pharmaceutics
|June 28, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a unified framework for surrogate-based optimization in pharmaceutical manufacturing. It enhances operational efficiency and yield by effectively approximating complex process models for Active Pharmaceutical Ingredient production.

Keywords:
Multi-objectivePharmaceutical industryProcess OptimisationSurrogate modelSustainability

More Related Videos

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.2K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

5.0K

Related Experiment Videos

Last Updated: Sep 17, 2025

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
09:28

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation

Published on: May 18, 2020

8.6K
Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.2K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

5.0K

Area of Science:

  • Chemical Engineering
  • Process Systems Engineering
  • Computational Chemistry

Background:

  • Pharmaceutical manufacturing relies on complex process models for optimization.
  • High computational demands of these models necessitate efficient alternative approaches.
  • Surrogate-based optimization offers a practical solution for complex system modeling.

Purpose of the Study:

  • To present a unified framework integrating multiple software tools for surrogate-based optimization.
  • To address challenges in optimizing complex real-world process models.
  • To improve key metrics like yield, purity, and sustainability in Active Pharmaceutical Ingredient (API) manufacturing.

Main Methods:

  • Development of a unified system for surrogate-based optimization.
  • Application of multi-objective optimization techniques.
  • Utilizing Pareto fronts for visualizing trade-offs between competing objectives.

Main Results:

  • Surrogate models effectively approximate complex process behaviors.
  • Single-objective optimization improved Yield by 1.72% and Process Mass Intensity by 7.27%.
  • Multi-objective optimization enhanced Yield by 3.63% while maintaining high purity.

Conclusions:

  • The presented framework provides a practical approach for robust optimization of API manufacturing flowsheets.
  • Surrogate-based optimization is an efficient strategy for improving pharmaceutical process performance.
  • Multi-objective optimization effectively balances competing performance metrics in drug manufacturing.